Abstract
Background: Microvolt level T-wave alternans (MTWA) is increasingly used for arrhythmia risk stratification. Particularly, its high negative predictive value points to a potential use as a risk stratifier in pts with ischemic cardiomyopathy. The value of MTWA assessed early after acute myocardial infarction (MI), however, seems to be limited. There are no data about the long-term course of MTWA in post-MI pts with reduced left ventricular ejection fraction (LVEF).
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call